Full text is available at the source.
Current obesity reports···
Combining obesity medications and personalized nutrition for better weight management
Updated
Funding
Competing interests
Declarations. Competing interests: The authors declare no competing interests.
PubMed
Related papers
Mar '25
Long-Term Health Benefits and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults
top 5% journal
cited by 47 papers
journal article
Jun '25
Comparing effectiveness and safety of tirzepatide (10 and 15 mg) and semaglutide (2.4 mg) for treating obesity and overweight in type 2 diabetes patients
top 5% journal
cited by 10 papers
randomized controlled trial
Oct '25
Combining Semaglutide Medication and Nutrition Therapy for Managing Obesity
top 5% journal
cited by 2 papers
journal article
Aug '25
Weight Loss with Semaglutide and Tirzepatide in People with Overweight or Obesity Without Diabetes
top 20% journal
cited by 23 papers
journal article
Mar '24
Strong weight loss effects and safety of semaglutide and tirzepatide for obesity: A review and analysis
top 5% journal
cited by 44 papers
systematic review
Dec '25
Real-world effects of incretin-based obesity drugs on body fat and muscle
top 20% journal
cited by 1 paper
journal article
Apr '25
Very Low-Energy Ketogenic Therapy as a New Approach to Obesity Management Compared to the Traditional Ketogenic Diet
top 5% journal
cited by 13 papers
journal article
Apr '25
Cost-effectiveness of tirzepatide compared to semaglutide and liraglutide for short-term weight loss in overweight or obese US patients without diabetes
top 20% journal
cited by 4 papers
comparative study
Dec '25
Adults' experiences using semaglutide and tirzepatide for obesity treatment
top 20% journal
cited by 2 papers
journal article